|
|
 |
|
|
|
 |
Carlos L. Arteaga, M.D.
Vanderbilt University Medical Center
Research Focus: Mechanisms of Resistance to Aromatase Inhibitors in
Breast Cancer |
|
|
| |
George Coukos,
M.D., Ph.D.
Trustees of the University of Pennsylvania
Research Focus: Immunotherapy of Ovarian Cancer |
|
|
 |
David A. Frank, M.D., Ph.D.
Dana-Farber Cancer Institute
Research Focus: STAT5 Isoforms in the Pathogenesis of Breast Cancer:
Differential Effects of Nearly Identical Transcription Factors |
|
|
 |
Thomas F.
Franke, M.D., Ph.D.
Columbia University in the City of New York, Dept. of Pharmacology
Research Focus: Therapeutic targets downstream of AKT Kinases |
|
|
 |
Scott Goode, Ph.D.
Baylor College of Medicine
Research Focus: Potent Suppressors of Tumorogenesis |
|
|
 |
Carol A.
Lange, Ph.D.
University of Minnesota Cancer Center
Research Focus: A Novel Kinase Target in Breast Cancer Cells |
|
|
 |
Susan J. Littman, M.D., M.S.
Duke University Medical Center
Research Focus: The Breast Cancer Susceptibility Gene, BRCA2:
Isolation and Study of Its Biological Activity in DNA Repair. |
|
|
| |
Karen M. Lounsbury, Ph.D.
The University of Vermont, College of Medicine
Research Focus: Interleukin-6 as a Regulator of Angiogenesis in
Ovarian Cancer |
|
|
| |
|
|